Board Disclosures
The American Academy of Neurology (AAN) Policy on Conflicts of Interest requires all members of the Board of Directors to complete a Disclosure Statement. Each Disclosure Statement is reviewed in accordance with the process described in the Policy on Conflicts of Interest.
Review the Policy on Conflicts of Interest and the Disclosure Statement.
The following are the disclosures reported by each member of the AAN Board of Directors.
Baumann, Robert J., MD, FAAN — compensation for providing expert witness testimony provided to institution.
Busis, Neil A., MD, FAAN — compensation for service as AAN.com Practice and Technology Editor, and consulting work on billing and coding for medical practices. Compensation for providing medical-legal consulting on coding and neurology issues.
Cascino, Gregory D., MD, FAAN — compensation for service as Associate Editor of Neurology®. Research support from NeuroPace, Inc. Research support from NIH.
Cascino, Terrence L., MD, FAAN — nothing to disclose.
DeAngelis, Lisa M., MD, FAAN —compensation for service on Genetech, Inc. advisory board.
Griggs, Robert C., MD, FAAN — compensation for service as editor of Neurotherapeutics textbooks (Elsevier, publisher). Research support to his institution (University of Rochester Medical Center) from Taro Pharmaceuticals, NIH, and MDA.
Gross, Robert A., MD, PhD, FAAN — compensation for service as Editor-in-Chief of Neurology®, education honoraria from AAN, educational support from the University of Rochester Medical Center's Clinical and Translational Science Award from the NIH.
Jackson, Carlayne E., MD, FAAN — compensation for consulting for Avanir Pharmaceuticals. Potential service on Avanir's speakers bureau. Research support from Knopp Pharmaceuticals.
Jozefowicz, Ralph F., MD, FAAN — compensation for service as member of "The Neurologist" editorial board.
Miller, Aaron E., MD, FAAN (last updated 2010) — compensation/travel expenses for service on scientific advisory boards for Sanofi-aventis, BiogenIdec, Glaxo-Smith Kline, EMD Serono, Teva Neuroscience, Daiichi-Sankyo, Merck, Novartis, ONO, and Acorda, speaker for Biogen Idec and EMD Serono. Compensation for service as Editor-in-Chief of Continuum: Lifelong Learning in Neurology®. Research support from Acorda, Teva Neuroscience, Novartis, Genentech, Genzyme, and Sanofi-aventis. Compensation for reviewing medical cases as an expert witness for the defense.
Miyasaki, Janis, MD, FAAN — compensation for service as speaker for Teva Pharmaceuticals, Schering Plough (scientific advisory board), and Biovail, member of the editorial board of the Movement Disorders Society (website editorial board). Research support paid to institution's research financial department (not personal compensation) from Teva Pharmaceuticals, Cephalon, Impax Laboratories Inc., and Neurogen. Funds paid to institution's research financial department from NIH, NCCAM, Michael J. Fox Foundation, Canadian Institute for Health Research, Common Drug Review, Ontario Drug Benefits Program, and Ministry of Health and Long Term Care (Ontario).
Pedley, Timothy A., MD, FAAN — compensation for service as senior editor of Neurology for UpToDate (electronic medical textbook). Royalty payments from Wolters Kluwer (Lippincott, Williams, and Wilkins) for editing. Honorarium and expense reimbursement for serving on the National Advisory Neurological Disorders and Stroke Council, NIH.
Pulst, Stefan M., MD, FAAN — compensation for service as consultant for Athena Neurosciences and speakers bureau for ApoPharma DSMB. Royalties from Cedar-Sinai Medical Center.
Rydell, Catherine M., CAE — nothing to disclose.
Shulman, Lisa M., MD, FAAN — compensation for service as Editor-in-Chief of Neurology Now Books™. Research support from Teva Pharmaceuticals. Research support from Michael J. Fox Foundation, NIH, The Rosalyn Newman Foundation, and The Eugenia Brin Professorship.
Sigsbee, Bruce, MD, FAAN — stipend from AAN for service as President of AAN.
Stevens, James C., MD, FAAN — compensation for services on Dick Blick (art supplier) Board of Directors. Research support from Sanofi-Aventis and Biogen.